{
    "metadata": {
        "input_documents": [
            "gnn paper 1.pdf",
            "gnn paper 2.pdf",
            "gnn paper 3.pdf",
            "gnn paper 4.pdf"
        ],
        "persona": {
            "role": "PhD Researcher in Computational Biology"
        },
        "job_to_be_done": "Prepare a comprehensive literature review focusing on methodologies, datasets, and performance benchmarks.",
        "processing_timestamp": "2025-07-28T16:14:34.930895Z"
    },
    "extracted_section": [
        {
            "document": "gnn paper 1.pdf",
            "page_number": 10,
            "section_title": "Experimental Setup",
            "importance_rank": 1
        },
        {
            "document": "gnn paper 3.pdf",
            "page_number": 8,
            "section_title": "Discovery of drug mechanisms",
            "importance_rank": 2
        },
        {
            "document": "gnn paper 3.pdf",
            "page_number": 2,
            "section_title": "Datasets",
            "importance_rank": 3
        },
        {
            "document": "gnn paper 3.pdf",
            "page_number": 10,
            "section_title": "Biomarker and pathway analysis",
            "importance_rank": 4
        },
        {
            "document": "gnn paper 1.pdf",
            "page_number": 5,
            "section_title": "Generation Algorithm",
            "importance_rank": 5
        },
        {
            "document": "gnn paper 1.pdf",
            "page_number": 3,
            "section_title": "The GNN Model",
            "importance_rank": 6
        },
        {
            "document": "gnn paper 3.pdf",
            "page_number": 3,
            "section_title": "Drug representation",
            "importance_rank": 7
        },
        {
            "document": "gnn paper 4.pdf",
            "page_number": 1,
            "section_title": "A comparison study of descriptorbased",
            "importance_rank": 8
        },
        {
            "document": "gnn paper 2.pdf",
            "page_number": 1,
            "section_title": "Graph Neural Networks",
            "importance_rank": 9
        },
        {
            "document": "gnn paper 1.pdf",
            "page_number": 1,
            "section_title": "Networks for Drug Discovery",
            "importance_rank": 10
        },
        {
            "document": "gnn paper 3.pdf",
            "page_number": 12,
            "section_title": "Data Availability",
            "importance_rank": 11
        },
        {
            "document": "gnn paper 3.pdf",
            "page_number": 1,
            "section_title": "OPEN",
            "importance_rank": 12
        },
        {
            "document": "gnn paper 3.pdf",
            "page_number": 5,
            "section_title": "Graph neural networks (GNN)",
            "importance_rank": 13
        },
        {
            "document": "gnn paper 1.pdf",
            "page_number": 11,
            "section_title": "Evaluation",
            "importance_rank": 14
        },
        {
            "document": "gnn paper 1.pdf",
            "page_number": 9,
            "section_title": "Dataset Description",
            "importance_rank": 15
        },
        {
            "document": "gnn paper 1.pdf",
            "page_number": 12,
            "section_title": "Results and Discussion",
            "importance_rank": 16
        },
        {
            "document": "gnn paper 3.pdf",
            "page_number": 7,
            "section_title": "Rediscovery of known drug and cell line responses",
            "importance_rank": 17
        },
        {
            "document": "gnn paper 1.pdf",
            "page_number": 8,
            "section_title": "Graph Preprocessing",
            "importance_rank": 18
        },
        {
            "document": "gnn paper 1.pdf",
            "page_number": 7,
            "section_title": "Implementation with Graph Neural Networks",
            "importance_rank": 19
        },
        {
            "document": "gnn paper 1.pdf",
            "page_number": 2,
            "section_title": "Introduction",
            "importance_rank": 20
        },
        {
            "document": "gnn paper 3.pdf",
            "page_number": 6,
            "section_title": "Model interpretability",
            "importance_rank": 21
        },
        {
            "document": "gnn paper 3.pdf",
            "page_number": 13,
            "section_title": "Competing interests",
            "importance_rank": 22
        },
        {
            "document": "gnn paper 1.pdf",
            "page_number": 17,
            "section_title": "Conclusions",
            "importance_rank": 23
        },
        {
            "document": "gnn paper 3.pdf",
            "page_number": 14,
            "section_title": "Additional information",
            "importance_rank": 24
        }
    ],
    "sub-section_analysis": [
        {
            "document": "gnn paper 1.pdf",
            "page_number": 10,
            "refined_text": "The dataset is split into a training set, a test set, and a validation set of 230,000, 10,000, 9,455 molecular graphs, respectively."
        },
        {
            "document": "gnn paper 3.pdf",
            "page_number": 8,
            "refined_text": "By interpreting a reaction pair of drug and cell line, each node and edge in the molecular graph is assigned with a saliency score."
        },
        {
            "document": "gnn paper 3.pdf",
            "page_number": 2,
            "refined_text": "Methods Datasets We propose a deep learning-based approach to predict the drug responses of cancer with molecular graphs of drugs and gene expression data from cancer cell lines."
        },
        {
            "document": "gnn paper 3.pdf",
            "page_number": 10,
            "refined_text": "For a clearer illustration, we leveraged the Extended Functional Groups (EFG) algorithm55 to identify the common functional groups in our dataset, and calculated the average of the saliency score of each atom in the functional group to present the importance of each functional group in the drug molecules."
        },
        {
            "document": "gnn paper 1.pdf",
            "page_number": 5,
            "refined_text": "3 Method Our method consists in a graph generation algorithm tailored to the production of small organic molecules, and its implementation with GNNs."
        },
        {
            "document": "gnn paper 1.pdf",
            "page_number": 3,
            "refined_text": "The main novelty of our approach consists in using the GNN framework for molecular graph generation, with a modular architecture, in order to maximize the information and make the generative model flexible."
        },
        {
            "document": "gnn paper 3.pdf",
            "page_number": 3,
            "refined_text": "Drug representation Previous research have demonstrated that representing drugs with molecular graphs provides better predictive power than compressed representations such as SMILES11,25, since the structural information of a molecule can be naturally preserved in a graph."
        },
        {
            "document": "gnn paper 4.pdf",
            "page_number": 1,
            "refined_text": "Mitchell JB (2014) Machine learning methods in chemoinformatics, Wiley Interdisciplinary Reviews: computational Molecular."
        },
        {
            "document": "gnn paper 2.pdf",
            "page_number": 1,
            "refined_text": "Altman, Machine learning in chemoinformatics and drug discovery, Drug Discovery Today, vol."
        },
        {
            "document": "gnn paper 1.pdf",
            "page_number": 1,
            "refined_text": "The design of new candidate molecules requires large amounts of time and money, and computational methods are being increasingly employed to cut these costs."
        }
    ]
}